Laura A. Vella

8.1k total citations
19 papers, 609 citations indexed

About

Laura A. Vella is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Laura A. Vella has authored 19 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Laura A. Vella's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Laura A. Vella is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Laura A. Vella collaborates with scholars based in United States, Sweden and Mexico. Laura A. Vella's co-authors include Olivera J. Finn, E. John Wherry, Ramin S. Herati, Ann Marie Egloff, Anne H. Rowley, Michael R. Betts, Pablo Tebas, David H. Canaday, Kenneth E. Schmader and Susan A. Doyle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Laura A. Vella

17 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura A. Vella United States 12 329 157 98 97 95 19 609
Veronica Bordoni Italy 19 369 1.1× 225 1.4× 178 1.8× 139 1.4× 113 1.2× 56 884
Abdul W. Ansari United States 16 368 1.1× 96 0.6× 148 1.5× 188 1.9× 110 1.2× 38 712
Ramy El–Diwany United States 11 209 0.6× 148 0.9× 56 0.6× 173 1.8× 99 1.0× 15 643
B. Wahren Sweden 10 291 0.9× 118 0.8× 90 0.9× 133 1.4× 56 0.6× 15 553
Keri Csencsits‐Smith United States 17 383 1.2× 135 0.9× 54 0.6× 105 1.1× 54 0.6× 26 686
Andréa Luciana Soares da Silva Brazil 5 387 1.2× 131 0.8× 64 0.7× 73 0.8× 88 0.9× 7 632
Keith Bishop United States 6 336 1.0× 159 1.0× 42 0.4× 56 0.6× 98 1.0× 7 584
Eiji Shinya Japan 16 455 1.4× 203 1.3× 58 0.6× 72 0.7× 290 3.1× 24 808
Marta Martínez‐Bonet Spain 14 195 0.6× 130 0.8× 176 1.8× 64 0.7× 57 0.6× 27 593
Andreas Heinold Germany 14 253 0.8× 193 1.2× 179 1.8× 136 1.4× 138 1.5× 36 797

Countries citing papers authored by Laura A. Vella

Since Specialization
Citations

This map shows the geographic impact of Laura A. Vella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura A. Vella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura A. Vella more than expected).

Fields of papers citing papers by Laura A. Vella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura A. Vella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura A. Vella. The network helps show where Laura A. Vella may publish in the future.

Co-authorship network of co-authors of Laura A. Vella

This figure shows the co-authorship network connecting the top 25 collaborators of Laura A. Vella. A scholar is included among the top collaborators of Laura A. Vella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura A. Vella. Laura A. Vella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Green, Jamal, Jean‐Bernard Lubin, Derek A. Oldridge, et al.. (2023). IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation. Science Immunology. 8(83). eade2335–eade2335. 39 indexed citations
3.
Wu, Vincent H., Son Nguyen, Perla M. Del Río Estrada, et al.. (2022). Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir. Nature Immunology. 24(2). 359–370. 53 indexed citations
4.
Downes, Kevin J., et al.. (2022). CMV infection and management among pediatric solid organ transplant recipients. Pediatric Transplantation. 26(3). e14220–e14220. 11 indexed citations
5.
Diorio, Caroline, Rawan Shraim, Laura A. Vella, et al.. (2021). Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction. Nature Communications. 12(1). 7222–7222. 41 indexed citations
6.
Blatz, Allison M., Kathleen Chiotos, Leslie Castelo‐Soccio, et al.. (2021). Cutaneous Findings in SARS-CoV-2-Associated Multisystem Inflammatory Disease in Children. Open Forum Infectious Diseases. 8(3). ofab074–ofab074. 9 indexed citations
7.
Herati, Ramin S., Laura A. Vella, Alexander Muselman, et al.. (2021). Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways. Cell Reports Medicine. 2(5). 100262–100262. 29 indexed citations
8.
Vella, Laura A. & Anne H. Rowley. (2021). Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children. Current Pediatrics Reports. 9(4). 83–92. 40 indexed citations
9.
Sayın, Ismail, Andrea J. Radtke, Laura A. Vella, et al.. (2018). Spatial distribution and function of T follicular regulatory cells in human lymph nodes. The Journal of Experimental Medicine. 215(6). 1531–1542. 90 indexed citations
10.
Herati, Ramin S., Alexander Muselman, Laura A. Vella, et al.. (2017). Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells. Science Immunology. 2(8). 107 indexed citations
11.
Sayın, Ismail, Andrea J. Radtke, Laura A. Vella, et al.. (2017). Human T follicular regulatory cells (Tfr) able to inhibit antibody production are enriched at the lymph node T-B border and rare in germinal centers. The Journal of Immunology. 198(Supplement_1). 152.7–152.7. 1 indexed citations
12.
Vella, Laura A., Ramin S. Herati, & E. John Wherry. (2017). CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective. Trends in Molecular Medicine. 23(12). 1072–1087. 41 indexed citations
13.
Muselman, Alexander, Ramin S. Herati, Laura A. Vella, et al.. (2016). Identification of flu-specific ICOS+CD38+ cTfh after influenza vaccination. The Journal of Immunology. 196(1_Supplement). 145.10–145.10. 1 indexed citations
14.
Fisher, Brian T. & Laura A. Vella. (2015). Infectious diseases approach to immunocompromised patients in the pediatric intensive care unit. Journal of Pediatric Intensive Care. 3(4). 305–313.
15.
Vella, Laura A., Canqing Yu, Steven R. Fuhrmann, et al.. (2009). Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer. Proceedings of the National Academy of Sciences. 106(33). 14010–14015. 39 indexed citations
16.
Vella, Laura A., et al.. (2009). Immunity against Cyclin B1 Tumor Antigen Delays Development of Spontaneous Cyclin B1‐Positive Tumors in p53−/− Mice. Annals of the New York Academy of Sciences. 1174(1). 68–73. 7 indexed citations
17.
Vella, Laura A. & Olivera J. Finn. (2006). Innate and Adaptive Immunity in Lung Cancer. Novartis Foundation symposium. 279. 206–215. 5 indexed citations
18.
Egloff, Ann Marie, Laura A. Vella, & Olivera J. Finn. (2006). Cyclin B1 and Other Cyclins as Tumor Antigens in Immunosurveillance and Immunotherapy of Cancer. Cancer Research. 66(1). 6–9. 83 indexed citations
19.
Vella, Laura A., et al.. (1991). Role of Drugs and Alcohol in Patients with Head Injury. Journal of the Royal Society of Medicine. 84(10). 608–610. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026